Secondary |
Product Used For Unknown Indication |
19.4% |
Cancer Pain |
18.0% |
Pain |
17.9% |
Analgesic Therapy |
9.0% |
Prophylaxis |
5.9% |
Constipation |
5.2% |
Drug Use For Unknown Indication |
3.8% |
Infection Prophylaxis |
2.8% |
Stem Cell Transplant |
2.5% |
Ill-defined Disorder |
2.0% |
Adult T-cell Lymphoma/leukaemia |
1.7% |
Anaemia |
1.5% |
Hydronephrosis |
1.5% |
Gastritis |
1.3% |
Infection |
1.3% |
Insomnia |
1.3% |
Foetal Exposure During Pregnancy |
1.2% |
Withdrawal Syndrome |
1.2% |
Cystitis Haemorrhagic |
1.2% |
Neuralgia |
1.1% |
|
Somnolence |
28.2% |
Stomatitis |
9.2% |
Drug Rash With Eosinophilia And Systemic Symptoms |
8.0% |
Rectal Perforation |
6.9% |
Withdrawal Syndrome |
5.2% |
Vomiting |
4.0% |
Wrong Technique In Drug Usage Process |
4.0% |
Cauda Equina Syndrome |
3.4% |
Drug Reaction With Eosinophilia And Systemic Symptoms |
3.4% |
Eating Disorder |
3.4% |
Ureteric Cancer |
3.4% |
Nausea |
2.9% |
Renal Impairment |
2.9% |
Cystitis |
2.3% |
Neutrophilia |
2.3% |
Respiratory Arrest |
2.3% |
Thrombocytopenia |
2.3% |
Treatment Noncompliance |
2.3% |
Drug Ineffective |
1.7% |
Overdose |
1.7% |
|
Concomitant |
Product Used For Unknown Indication |
24.6% |
Prophylaxis |
13.6% |
Pain |
11.4% |
Cancer Pain |
9.8% |
Constipation |
5.0% |
Drug Use For Unknown Indication |
4.8% |
Hypertension |
4.6% |
Acute Myeloid Leukaemia |
3.3% |
Renal Cell Carcinoma |
2.5% |
Insomnia |
2.3% |
Metastatic Renal Cell Carcinoma |
2.1% |
Nausea |
2.0% |
Gastritis |
1.9% |
Infection Prophylaxis |
1.9% |
Hyperlipidaemia |
1.9% |
Multiple Myeloma |
1.9% |
Prophylaxis Of Nausea And Vomiting |
1.8% |
Immunosuppression |
1.8% |
Constipation Prophylaxis |
1.5% |
Vomiting |
1.4% |
|
Vomiting |
14.9% |
Drug Prescribing Error |
7.8% |
Sepsis |
6.7% |
White Blood Cell Count Decreased |
6.0% |
Ileus |
5.3% |
Renal Impairment |
5.0% |
Somnolence |
5.0% |
Pancreatic Carcinoma |
4.6% |
Pyrexia |
4.6% |
Thrombocytopenia |
4.6% |
Urinary Tract Infection |
4.6% |
Wrong Technique In Drug Usage Process |
4.3% |
Stomatitis |
3.9% |
Nausea |
3.5% |
Platelet Count Decreased |
3.5% |
Urine Output Decreased |
3.5% |
Delirium |
3.2% |
Respiratory Failure |
3.2% |
Interstitial Lung Disease |
2.8% |
Malignant Neoplasm Progression |
2.8% |
|
Interacting |
Product Used For Unknown Indication |
20.6% |
Cancer Pain |
17.6% |
Herpes Zoster |
17.6% |
Pain |
14.7% |
Back Pain |
11.8% |
Drug Use For Unknown Indication |
5.9% |
Hypertension |
5.9% |
Abdominal Pain Lower |
2.9% |
Headache |
2.9% |
|
Vomiting |
20.0% |
Headache |
13.3% |
Respiratory Depression |
13.3% |
Vision Blurred |
13.3% |
Drug Ineffective |
6.7% |
Drug Interaction |
6.7% |
Flatulence |
6.7% |
Herpes Zoster |
6.7% |
Pain |
6.7% |
Pollakiuria |
6.7% |
|